PMGC Holdings Announces 1-for-4 Reverse Stock Split, Reducing Shares to 508,721
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1h ago
0mins
Source: Newsfilter
- Reverse Stock Split Implementation: PMGC Holdings will execute a 1-for-4 reverse stock split on January 6, 2026, reducing the outstanding shares to approximately 508,721, which is expected to enhance the per-share price and improve market appeal.
- Impact on Shareholders: All shareholders will see their shares adjusted proportionally, ensuring that the overall value of equity remains unchanged, as every four shares will consolidate into one, simplifying the capital structure.
- Trading Symbol Remains Unchanged: While the CUSIP number will be updated to 73017P409, the trading symbol
Analyst Views on ELAB
About ELAB
PMGC Holdings Inc. is a management, advisory, and investment company specializing in United States (U.S.)-based opportunities across financial services, manufacturing, and healthcare. The Company's portfolio consists of various subsidiaries: Northstrive Biosciences Inc., PMGC Research Inc., PMGC Capital LLC, and AGA Precision Systems LLC. Northstrive Biosciences Inc. is a biopharmaceutical company focusing on the development and acquisition of aesthetic medicines. Its lead asset, EL-22, is leveraging a first-in-class engineered probiotic approach to address obesity’s pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. PMGC Research Inc. is focused on advancing the frontiers of scientific discovery. PMGC Capital LLC is a multi-strategy investment firm focused on direct investments, strategic lending, and acquiring undervalued companies and assets across diverse markets. AGA Precision Systems LLC specializes in CNC machining operations.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
